Alba M A, Espinosa J, Cortinas de Nava C
Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México.
Environ Mol Mutagen. 1988;12(1):65-73. doi: 10.1002/em.2860120109.
Drugs containing secondary aliphatic amines, heterocyclic nitrogen, or secondary aliphatic amido groups (chloroquine, dehydroemetine, mebendazole, and piperazine) and pyrimidine derivatives such as pyrantel pamoate were reacted in vitro with sodium nitrite at pH 3.7 and became mutagenic for Salmonella typhimurium strain TA1535. The products derived from the nitrosation of chloroquine and dehydroemetine required metabolic activation by mammalian hepatic S9 to be mutagenic. The N-nitroso derivatives of mebendazole, piperazine, and pyrantel pamoate were mutagenic with and without S9, although more activity was noted in the presence of S9 with the nitrosated compounds formed from mebendazole and piperazine. Under identical conditions, no mutagenic products were detected from quaternary ammonium salts such as bephenium hydroxynaphthoate or drugs containing tertiary heterocyclic amino groups, such as iodochlorhydroxyquin.
含有仲脂肪胺、杂环氮或仲脂肪酰胺基的药物(氯喹、去氢依米丁、甲苯达唑和哌嗪)以及嘧啶衍生物如噻嘧啶,在体外pH 3.7条件下与亚硝酸反应后,对鼠伤寒沙门氏菌TA1535菌株具有致突变性。氯喹和去氢依米丁亚硝化反应产生的产物需经哺乳动物肝脏S9代谢激活才具有致突变性。甲苯达唑、哌嗪和噻嘧啶的N-亚硝基衍生物无论有无S9均具有致突变性,不过由甲苯达唑和哌嗪形成的亚硝化化合物在有S9存在时活性更高。在相同条件下,从季铵盐如羟萘苄芬宁或含有叔杂环氨基的药物如氯碘羟喹中未检测到致突变产物。